Molecular Characterization of Alpha Thalassemia via Multiplex Ligation Dependent Probe Amplification in Konya, Turkey: A Single Center Study

EMİNE GÖKTAŞ, Sümeyye ŞANAL, HÜSEYİN TOKGÖZ, AYŞE GÜL ZAMANİ, MAHMUT SELMAN YILDIRIM

  • EMİNE GÖKTAŞ: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • HÜSEYİN TOKGÖZ: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • AYŞE GÜL ZAMANİ: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • MAHMUT SELMAN YILDIRIM: SELÇUK ÜNİVERSİTESİ
  • Year : 2025
  • Vol : 41
  • Issue : 2
  •  Page : 61-65
ABSTRACT
Objective: Alpha thalassemia is an autosomal recessive hemoglobinopathy characterized by hypochromic microcytic anemia, exhibiting variable clinical phenotypes. Eighty-five percent of cases arise from deletions in the HBA1 or HBA2 genes. The objective of this study is to present the results of Multiplex Ligation Dependent Probe Amplification (MLPA) analysis of patients under the age of 18 with a preliminary diagnosis of alpha thalassemia.
Material and Methods: The present study examined alpha globin copy number variations determined by the MLPA method in patients who were followed up in the Pediatric Hematology department and referred to the Medical Genetics outpatient clinic with a preliminary diagnosis of alpha thalassemia between 2021-2023. We analyzed the hemogram parameters and hemoglobin electrophoresis results of the patients with deletions detected by MLPA and correlated them with their genotypes.
Results: A deletion was identified in 15 (51.7%) of 29 patients with a preliminary diagnosis of alpha thalassaemia. In eleven patients, one α-globin gene copy was deleted, while two α-globin gene copies were deleted in four patients. The most prevalent deletion was -α3.7 (36.7%), followed by -α20.5 (16.7%) and -αMED-1(6.6%). Biallelic observation of different forms of the -α3.7 deletion [-α3.7(A)/- α3.7(D), -α3.7(D) /- α3.7(F)] was noted in two cases. Additionally, one case showed biallelic -a3.7(D) deletion along with (-α)20.5 biallelic deletion, and in another case, besides -α3.7(D) deletion, a pathogenic variant p.Gly60Asp was detected in the HBA1 gene through sequence analysis.
Conclusion: Since 85% of alpha thalassemia etiology is attributed to α-globin gene deletions, the molecular genetic diagnosis rate is considerably high with MLPA analysis. In alpha thalassemia cases where MLPA analysis is normal or identified α-globin gene copy numbers that do not explain the phenotypic findings, sequencing analysis of the HBA1 and HBA2 genes should be considered.
Keywords: Alpha thalassemia, deletion, MLPA, amplification
Cite this Article As : Goktas E, Sanal S, Tokgoz H, Zamani AG, Yildirim MS. Molecular Characterization of Alpha Thalassemia via Multiplex Ligation Dependent Probe Amplification in Konya, Turkey: A Single Center Study. Selcuk Med J 2025;41(2): 61-65

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : The authors declare that they have no conflict of interest.
This article is published under the CC BY-NC 4.0 license.
Selcuk Medical Journal
2025, Vol. 41 (2)
ISSN: 1017-6616
E-ISSN: 2149-8059
Received : , Accepted : , Published Online :

References

  1. 1. Musallam KM, Cappellini MD, Coates TD, et al. Αlpha-thalassemia: A practical overview. Blood Rev. 2024;64:101165. doi:10.1016/j.blre.2023.101165.
  2. 2. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-487. doi:10.2471/blt.06.036673.
  3. 3. Farashi S, Harteveld CL. Molecular basis of α-thalassemia. Blood Cells Mol Dis. 2018;70:43-53. doi:10.1016/j.bcmd.2017.09.004.
  4. 4. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010;5:13. doi:10.1186/1750-1172-5-13.
  5. 5. Galanello R, Cao A. Gene test review. Alpha-thalassemia. Genet Med. 2011;13(2):83-88. doi:10.1097/GIM.0b013e3181fcb468.
  6. 6. Tamary H, Dgany O. Alpha-Thalassemia. 2005 Nov 1 [Updated 2020 Oct 1]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1435/
  7. 7. Stuppia L, Antonucci I, Palka G et al. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci. 2012;13(3):3245-3276. doi:10.3390/ijms13033245.
  8. 8. Demir S, Gürkan H, Eker D, et al. Retrospectıve analysıs of alpha globın copy number varıatıons determıned by mlpa ın the trakya regıon. Istanbul Tip Fakultesi Dergisi. 2021;84(3):348–53. doi:10.26650/IUITFD.2021.880592.
  9. 9. Onay H, Aykut A, Karaca E et al. Molecular spectrum of α-globin gene mutations in the Aegean region of Turkey: first observation of three α-globin gene mutations in the Turkish population. Int J Hematol. 2015;102(1):1–6. doi:10.1007/s12185-015-1796-y.
  10. 10. Celik MM, Gunesacar R, Oktay G et al. Spectrum of α-thalassemia mutations including first observation of - -(FIL) deletion in Hatay Province, Turkey. Blood Cells Mol Dis. 2013;51(1):27-30. doi:10.1016/j.bcmd.2013.01.012.
  11. 11. Karakaş Z, Koç B, Temurhan S et al. Hipokromik Mikrositer Anemili Olgularda Alfa Talasemi Mutasyonlarının Değerlendirmesi: İstanbul Perspektifi. Turkish Journal of Hematology. 2015;32(4):344–50. doi: 10.4274/tjh.2014.0204.
  12. 12. Barış S, Yavaş C, Balasar Ö et al. Batı Ege Bölgesinde α-Talasemi Genotipleri ve α-Talasemi Genotip Frekansı. Sağlık Bilimlerinde Değer. 2023;13(2):257–62. https://doi.org/10.33631/sabd.1247255.
  13. 13. Benz EJ. Vichinsky, Elliott P. Molecular genetics of the thalassemia syndromes. [Internet]. Available from: https://medilib.ir/uptodate/show/7131 Date:May 2024.
  14. 14. Velasco-Rodríguez D, Blas C, Alonso-Domínguez JM, et al. Cut-off values of hematologic parameters to predict the number of alpha genes deleted in subjects with deletional alpha thalassemia. Int J Mol Sci. 2017;18(12). doi:10.3390/ijms18122707.
  15. 15. Colosimo A, Gatta V, Guida V, et al. Application of MLPA assay to characterize unsolved α-globin gene rearrangements. Blood Cells Mol Dis. 2011;46(2):139–44. doi:10.1016/j.bcmd.2010.11.006.
Figure 1
Figure 1